Emerging SARS-CoV-2 Variants in Uganda in the Era of COVID-19 Vaccination.

doi:10.3390/v16121860

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Emerging SARS-CoV-2 Variants in Uganda in the Era of COVID-19 Vaccination.

Viruses - 29 Nov 2024

Bbosa Nicholas, Kiiza Ronald, Ssekagiri Alfred, Namagembe Hamidah Suubi, Nabirye Stella Esther, Kabuuka Danstan, Rwankindo Cleophous, Kisakye Annet, Woldemariam Yonas T, Kusemererwa Sylvia, Ongaria Terry A, Kakande Ayoub, Abaasa Andrew, Kimbugwe Geofrey, Bosa Henry Kyobe, Driwale Alfred, Mwenda Jason M, Worwui Archibald K, Humphreys James, Cohuet Sandra, Elliott Alison M, Ruzagira Eugene, Kaleebu Pontiano, Ssemwanga Deogratius

Abstract excerpt

The emergence of SARS-CoV-2 variants has heightened concerns about vaccine efficacy, posing challenges in controlling the spread of COVID-19. As part of the COVID-19 Vaccine Effectiveness and Variants (COVVAR) study in Uganda, this study aimed to genotype and characterize SARS-CoV-2 variants in patients with COVID-19-like symptoms who tested positive on a real-time PCR. Amplicon deep sequencing was performed on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19 Vaccines

Share to Genome, Viral

Share to High-Throughput Nucleotide Sequencing

Source

Open in PubMed

Identifiers

PMID: 39772170
DOI: 10.3390/v16121860

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Emerging SARS-CoV-2 Variants in Uganda in the Era of COVID-19 Vaccination.PMID 39772170Read ↗

Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda.Semantic proximity Read ↗

COVID-19 in 16 West African Countries: An Assessment of the Epidemiology and Genetic Diversity of SARS-CoV-2 after Four Epidemic Waves.Semantic proximity Read ↗

Genetic diversity and transmission dynamics of SARS-CoV-2 in East Africa.Semantic proximity Read ↗

Screening and Whole Genome Sequencing of SARS-CoV-2 Circulating During the First Three Waves of the COVID-19 Pandemic in Libreville and the Haut-Ogooué Province in GabonSemantic proximity Read ↗

Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity — IVY Network, 26 Hospitals, October 18, 2023–March 9, 2024Semantic proximity Read ↗

The genomic diversity of SARS-CoV-2 Omicron lineages collected during routine sentinel surveillance in Tanzania between November 2022 and July 2023.Semantic proximity Read ↗

The outbreak of SARS‐CoV‐2 Omicron lineages, immune escape, and vaccine effectivitySemantic proximity Read ↗

Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concernSemantic proximity Read ↗

Main Routes of Entry and Genomic Diversity of SARS-CoV-2, Uganda.Semantic proximity Read ↗

Mutation mapping and evolutionary dynamics of Bundibugyo Ebolavirus (BDBV-2026) genomes reported from UgandaSemantic proximity Read ↗

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein VaccineSemantic proximity Read ↗

Changing impact of COVID-19 vaccination on COVID-19 mortality in the SARS-CoV-2 omicron variant period, 2022-2025Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.